Osteoporosis in multiple myelomatosis, multiple sites (Q101947): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/661446336
@@ Property / Canonical URI: https://id.who.int/icd/entity/661446336 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_661446336
@@ Property / CURIE: CID11:ID_661446336 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_661446336
@@ Property / Canary Token: dki-india-ID_661446336 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 18:48, 16 August 2026

This is a disease of bones that leads to an increased risk of fracture. In osteoporosis, the bone mineral density (BMD) is reduced, bone microarchitecture deteriorates, and the amount and variety of proteins in bone are altered. This diagnosis is in a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies, multiple sites.

Language	Label	Description	Also known as
default for all languages	ID_661446336
English	Osteoporosis in multiple myelomatosis, multiple sites	This is a disease of bones that leads to an increased risk of fracture. In osteoporosis, the bone mineral density (BMD) is reduced, bone microarchitecture deteriorates, and the amount and variety of proteins in bone are altered. This diagnosis is in a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies, multiple sites.